Synthesis and in Vitro Evaluation of a Series of Diketopiperazine Inhibitors of Plasminogen Activator Inhibitor-1
Overview
Affiliations
We have synthesized and evaluated a series of diketopiperazine-based inhibitors of PAI-1. These studies resulted in the identification of 34 which inhibited PAI-1 in vitro with an IC(50)=0.2 microM. The synthesis and SAR of these compounds are described.
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target.
Altalhi R, Pechlivani N, Ajjan R Int J Mol Sci. 2021; 22(6).
PMID: 33804680 PMC: 8003717. DOI: 10.3390/ijms22063170.
Cyclodipeptides: An Overview of Their Biosynthesis and Biological Activity.
Mishra A, Choi J, Choi S, Baek K Molecules. 2017; 22(10).
PMID: 29065531 PMC: 6151668. DOI: 10.3390/molecules22101796.
Deepa I, Kumar S, Sreerag R, Nath V, Mohandas C Front Microbiol. 2015; 6:876.
PMID: 26379651 PMC: 4548193. DOI: 10.3389/fmicb.2015.00876.
Simone T, Higgins S, Higgins C, Lennartz M, Higgins P J Mol Genet Med. 2015; 8(3).
PMID: 26110015 PMC: 4476021. DOI: 10.4172/1747-0862.1000125.
Chen X, Mou Y, Ling J, Wang N, Wang X, Hu J World J Microbiol Biotechnol. 2014; 31(1):247-53.
PMID: 25344087 DOI: 10.1007/s11274-014-1759-0.